Roger J Bedimo

Summary

Country: USA

Publications

  1. doi request reprint Body-fat abnormalities in patients with HIV: progress and challenges
    Roger J Bedimo
    Internal Medicine, Infectious Diseases Section, VA North Texas Healthcare System, UT Southwestern Medical School, Dallas, Texas, USA
    J Int Assoc Physicians AIDS Care (Chic) 7:292-305. 2008
  2. ncbi request reprint Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients
    Roger Bedimo
    Infectious Diseases Section, Medical Service, Veterans Affairs North Texas Healthcare System, Dallas, TX, USA
    Curr HIV/AIDS Rep 13:328-339. 2016
  3. pmc Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
    Roger Bedimo
    Infectious Disease Section, VA North Texas Health Care System, TX, USA
    HIV AIDS (Auckl) 3:69-79. 2011
  4. doi request reprint Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients
    R Bedimo
    Veterans Affairs North Texas Health Care System, Dallas, TX 75216, USA
    HIV Med 13:345-51. 2012
  5. doi request reprint Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
    Roger Bedimo
    Department of Medicine, VA North Texas Healthcare System, Dallas, Texas, USA
    AIDS 26:825-31. 2012
  6. doi request reprint Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients
    R Bedimo
    Department of Medicine, VA North Texas Health Care System, Dallas, 75216, USA
    HIV Med 11:462-8. 2010
  7. pmc Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression
    Roger J Bedimo
    Department of Medicine, Veterans Affairs North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, TX 75216, USA
    J Acquir Immune Defic Syndr 52:203-8. 2009
  8. pmc Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
    Ronald G Hall
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy, Dallas, TX, USA
    BMC Pharmacol Toxicol 14:12. 2013
  9. pmc Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia
    Carlos A Alvarez
    Department of Pharmacy Practice CAA, KAT, SDB, RGH, Texas Tech University Health Sciences Center, School of Pharmacy, Dallas, Texas Departments of Clinical Sciences CAA, EMM, RGH and Internal Medicine EMM, RJB, University of Texas Southwestern, Dallas, Texas Department of Pharmacy Practice CAG, KKH, Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo, Texas Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences CAG, Wayne State University CAG, Department of Pharmacy Practice OU Medical System KAT, Department of Pharmacy Mission Regional Medical Center NAF, Department of Pharmacy University of Kentucky Healthcare SDB, Department of Pharmacy Detroit, Michigan OU Medical System KAT, Oklahoma City, Oklahoma Division of Pharmacotherapy CRF, NAF, University of Texas, Austin, Texas Mission Regional Medical Center NAF, Mission, Texas University of Kentucky Healthcare SDB, Lexington, Kentucky Section of General Internal Medicine EMM, VA North Texas Health Care System, Dallas
    Am J Med Sci 348:371-6. 2014
  10. doi request reprint Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era
    Roger J Bedimo
    VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
    Clin Infect Dis 53:84-91. 2011

Collaborators

Detail Information

Publications14

  1. doi request reprint Body-fat abnormalities in patients with HIV: progress and challenges
    Roger J Bedimo
    Internal Medicine, Infectious Diseases Section, VA North Texas Healthcare System, UT Southwestern Medical School, Dallas, Texas, USA
    J Int Assoc Physicians AIDS Care (Chic) 7:292-305. 2008
    ..This information may assist physicians in identifying individual risk factors and choosing the type of antiretroviral therapy that may minimize these changes without loss of virologic suppression...
  2. ncbi request reprint Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients
    Roger Bedimo
    Infectious Diseases Section, Medical Service, Veterans Affairs North Texas Healthcare System, Dallas, TX, USA
    Curr HIV/AIDS Rep 13:328-339. 2016
    ..We will finally review the impact of control of HCV viremia on the cardio-metabolic morbidity and mortality of HIV/HCV-co-infected patients...
  3. pmc Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
    Roger Bedimo
    Infectious Disease Section, VA North Texas Health Care System, TX, USA
    HIV AIDS (Auckl) 3:69-79. 2011
    ..This effect is transient, however, and its association with improved cardiovascular risk remains unclear...
  4. doi request reprint Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients
    R Bedimo
    Veterans Affairs North Texas Health Care System, Dallas, TX 75216, USA
    HIV Med 13:345-51. 2012
    ..The aim of the study was to determine the prognostic value of HIV replication capacity (RC) for subsequent antiretroviral (ARV) treatment response in ARV-experienced patients...
  5. doi request reprint Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
    Roger Bedimo
    Department of Medicine, VA North Texas Healthcare System, Dallas, Texas, USA
    AIDS 26:825-31. 2012
    ..Whereas tenofovir (TDF) exposure has been associated with decreased bone density, it remains unclear whether it is associated with increased risk of osteoporotic fractures...
  6. doi request reprint Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients
    R Bedimo
    Department of Medicine, VA North Texas Health Care System, Dallas, 75216, USA
    HIV Med 11:462-8. 2010
    ..Among HIV-infected patients, hepatitis C virus (HCV) coinfection is associated with lower cholesterol levels, but it remains unclear how it affects cardiovascular outcomes...
  7. pmc Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression
    Roger J Bedimo
    Department of Medicine, Veterans Affairs North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, TX 75216, USA
    J Acquir Immune Defic Syndr 52:203-8. 2009
    ..Whether incidence of non-ADM is significantly higher in HIV-infected than in HIV-uninfected patients remains unclear...
  8. pmc Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
    Ronald G Hall
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy, Dallas, TX, USA
    BMC Pharmacol Toxicol 14:12. 2013
    ..However, data are currently lacking regarding the effect of guideline-recommended weight-based dosing on nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteremia (MRSAB)...
  9. pmc Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia
    Carlos A Alvarez
    Department of Pharmacy Practice CAA, KAT, SDB, RGH, Texas Tech University Health Sciences Center, School of Pharmacy, Dallas, Texas Departments of Clinical Sciences CAA, EMM, RGH and Internal Medicine EMM, RJB, University of Texas Southwestern, Dallas, Texas Department of Pharmacy Practice CAG, KKH, Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo, Texas Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences CAG, Wayne State University CAG, Department of Pharmacy Practice OU Medical System KAT, Department of Pharmacy Mission Regional Medical Center NAF, Department of Pharmacy University of Kentucky Healthcare SDB, Department of Pharmacy Detroit, Michigan OU Medical System KAT, Oklahoma City, Oklahoma Division of Pharmacotherapy CRF, NAF, University of Texas, Austin, Texas Mission Regional Medical Center NAF, Mission, Texas University of Kentucky Healthcare SDB, Lexington, Kentucky Section of General Internal Medicine EMM, VA North Texas Health Care System, Dallas
    Am J Med Sci 348:371-6. 2014
    ..Therefore, a subanalysis of the effect of guideline-recommended vancomycin dosing on in-hospital mortality and nephrotoxicity in ICU patients with MRSA bacteremia was conducted...
  10. doi request reprint Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era
    Roger J Bedimo
    VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
    Clin Infect Dis 53:84-91. 2011
    ..Some studies have suggested that exposure to antiretroviral therapy (ART) with abacavir is associated with an increased risk of acute myocardial infarction (AMI)...
  11. pmc The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health
    Roger J Bedimo
    Department of Medicine, VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
    PLoS ONE 9:e106221. 2014
    ..NRTI-sparing regimens may avoid long-term mitochondrial, bone and renal toxicities and maintain viral suppression...
  12. pmc Fracture Prediction With Modified-FRAX in Older HIV-Infected and Uninfected Men
    Michael T Yin
    Department of Medicine, Columbia University Medical Center, New York, NY Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY VA Medical Center, Emory University School of Medicine, Atlanta, GA VA Medical Center and Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC VA North Texas Healthcare System, Dallas, TX Michael E DeBakey VA Medical Center, Infectious Diseases Section, and Department of Medicine, Baylor College of Medicine, Houston, TX Arcadia Healthcare Solutions, New York, NY Yale School of Medicine, New Haven, CT VA Connecticut Healthcare System, West Haven, CT and Yale School of Nursing, West Haven, CT
    J Acquir Immune Defic Syndr 72:513-20. 2016
    ..Some experts recommend considering HIV as a cause of secondary osteoporosis when calculating FRAX in HIV-infected individuals...
  13. pmc Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012
    Lesley S Park
    aStanford University School of Medicine, Stanford, California bVeterans Affairs Connecticut Healthcare System, West Haven cYale School of Medicine, New Haven, Connecticut dIcahn School of Medicine at Mt Sinai, New York, New York eAtlanta Veterans Affairs Medical Center fEmory University School of Medicine, Atlanta, Georgia gUniversity of Washington School of Medicine, Seattle, Washington hWashington DC Veterans Affairs Medical Center iGeorge Washington University School of Medicine and Health Sciences, Washington, District of Columbia jMichael E DeBakey Veterans Affairs Medical Center kBaylor College of Medicine, Houston, Texas lVeterans Affairs Greater Los Angeles Healthcare System mDavid Geffen School of Medicine, University of California, Los Angeles, California nVeterans Affairs North Texas Healthcare System oUniversity of Texas Southwestern Medical Center, Dallas, Texas pJames J Peters Veterans Affairs Medical Center, New York, New York qYale School of Public Health, New Haven, Connecticut, USA
    AIDS 30:1795-806. 2016
    ....
  14. pmc Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
    Ronald G Hall
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy, Dallas, TX, USA
    BMC Infect Dis 12:104. 2012
    ..No studies have evaluated the effect of guideline-recommended weight-based dosing on in-hospital mortality of patients with methicillin-resistant Staphylococcus aureus bacteremia...